세계의 생명과학 BPO 시장 : 서비스 유형별, 용도별, 지역별(2025-2033년)

The global life sciences BPO market size reached USD 443.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 847.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.08% during 2025-2033. The growing need for efficient and effective problem resolution and management, enhanced focus on research and development (R&D) activities, rapid technological advancements, and significant growth in the healthcare industry represent some of the key factors driving the market.

Life sciences business process outsourcing (BPO) involves outsourcing various business processes and functions to a third-party provider in the life sciences industry. It provides specialized services to support the operations and growth of organizations. It is widely used in clinical trials, pharmacovigilance, medical writing, and data management. Life sciences BPO offers various advantages, including access to specialized expertise, cost savings, operational efficiency, scalability, and improved regulatory compliance. It encompasses a broad range of activities and services that support the operations, research, development, manufacturing, and regulatory compliance of companies in the life sciences field, which includes pharmaceuticals, biotechnology, medical devices, clinical research, and healthcare.

Life Sciences BPO Market Trends:

The increasing prevalence of chronic diseases across the globe is one of the key factors driving the market growth. Life sciences BPO providers help to collect, analyze, organize, and report complex healthcare data. In line with this, BPO services enable better insights into disease patterns, treatment outcomes, and patient populations, contributing to the development of personalized medicine and evidence-based healthcare solutions, which in turn is favoring the market growth. Apart from this, rapid technological advancements, such as cloud computing, big data analytics, artificial intelligence (AI), and robotic process automation (RPA), enable BPO providers to offer advanced data management, analytics, and automation solutions are providing an impetus to the market growth. Moreover, life sciences BPO offers cost-saving opportunities for companies by reducing operational costs associated with infrastructure setup, staffing, training, and maintenance, which is positively influencing the market growth. Other factors, including the growing need for efficient and effective problem resolution and management, enhanced focus on research and development (R&D) activities, the increasing complexity of the information technology (IT) environment, and significant growth in the pharmacovigilance sector, are anticipated to drive the market growth.

Key Market Segmentation:

Service Type Insights:

• Pharmaceutical Outsourcing
• Contract Manufacturing Organizations
• API
• Finished Dose Form
• Packaging
• Contract Research Organizations
• Drug Discovery
• Preclinical Studies
• Clinical Trial Studies
• Regulatory Services
• Pharmacovigilance
• Medical Devices Outsourcing
• Contract Manufacturing Organizations
• Electronic Manufacturing Services
• Finished Goods
• Raw Materials/ Components
• Contract Research Organizations
• Regulatory Consulting Services
• Product Design and Development Services
• Product Testing Services
• Product Upgrade Services
• Product Maintenance Services
• Contract Sales and Marketing Outsourcing

Application Insights:

• Clinical Trials
• Patient-Centric
• R&D Activities
• Digital Era

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific was the largest market for life sciences BPO. Some of the factors driving the Asia Pacific life sciences BPO market included the growing need for efficient and effective problem resolution and management, enhanced focus on research and development (R&D) activities, and rapid technological advancements.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global life sciences BPO market. Detailed profiles of all major companies have been provided. Some of the companies covered include Accenture plc, Cognizant, Genpact Ltd., IQVIA Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global life sciences BPO market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global life sciences BPO market?
• What is the impact of each driver, restraint, and opportunity on the global life sciences BPO market?
• What are the key regional markets?
• Which countries represent the most attractive life sciences BPO market?
• What is the breakup of the market based on service type?
• Which is the most attractive service type in the life sciences BPO market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the life sciences BPO market?
• What is the competitive structure of the global life sciences BPO market?
• Who are the key players/companies in the global life sciences BPO market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Life Sciences BPO Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Service Type

• 6.1 Pharmaceutical Outsourcing
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Contract Manufacturing Organizations
      • 6.1.2.1.1 API
      • 6.1.2.1.2 Finished Dose Form
      • 6.1.2.1.3 Packaging
    • 6.1.2.2 Contract Research Organizations
      • 6.1.2.2.1 Drug Discovery
      • 6.1.2.2.2 Preclinical Studies
      • 6.1.2.2.3 Clinical Trial Studies
      • 6.1.2.2.4 Regulatory Services
      • 6.1.2.2.5 Pharmacovigilance
  • 6.1.3 Market Forecast
• 6.2 Medical Devices Outsourcing
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Contract Manufacturing Organizations
      • 6.2.2.1.1 Electronic Manufacturing Services
      • 6.2.2.1.2 Finished Goods
      • 6.2.2.1.3 Raw Materials/ Components
    • 6.2.2.2 Contract Research Organizations
      • 6.2.2.2.1 Regulatory Consulting Services
      • 6.2.2.2.2 Product Design and Development Services
      • 6.2.2.2.3 Product Testing Services
      • 6.2.2.2.4 Product Implementation Services
      • 6.2.2.2.5 Product Upgrade Services
      • 6.2.2.2.6 Product Maintenance Services
  • 6.2.3 Market Forecast
• 6.3 Contract Sales and Marketing Outsourcing
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 Clinical Trials
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Patient-Centric
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 R&D Activities
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Digital Era
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

• 9.1 Overview
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Accenture plc
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Cognizant
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Genpact Ltd.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 IQVIA Inc.
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.